AU2003276957A1 - Quaternised ammonium cyclodextrin compounds - Google Patents

Quaternised ammonium cyclodextrin compounds

Info

Publication number
AU2003276957A1
AU2003276957A1 AU2003276957A AU2003276957A AU2003276957A1 AU 2003276957 A1 AU2003276957 A1 AU 2003276957A1 AU 2003276957 A AU2003276957 A AU 2003276957A AU 2003276957 A AU2003276957 A AU 2003276957A AU 2003276957 A1 AU2003276957 A1 AU 2003276957A1
Authority
AU
Australia
Prior art keywords
compound
alkylene
group selected
cyclodextrin
cyclodextrin compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003276957A
Other languages
English (en)
Inventor
Georg Ludwig Kis
Christian Schoch
Jozsef Szejtli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Publication of AU2003276957A1 publication Critical patent/AU2003276957A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/724—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AU2003276957A 2002-06-13 2003-06-12 Quaternised ammonium cyclodextrin compounds Abandoned AU2003276957A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP02013074 2002-06-13
EP02013074.6 2002-06-13
EP02028554 2002-12-20
EP02028554.0 2002-12-20
PCT/EP2003/006192 WO2003105867A1 (en) 2002-06-13 2003-06-12 Quaternised ammonium cyclodextrin compounds

Publications (1)

Publication Number Publication Date
AU2003276957A1 true AU2003276957A1 (en) 2003-12-31

Family

ID=29737927

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003276957A Abandoned AU2003276957A1 (en) 2002-06-13 2003-06-12 Quaternised ammonium cyclodextrin compounds

Country Status (15)

Country Link
US (4) US20050222085A1 (enExample)
EP (1) EP1515729B1 (enExample)
JP (2) JP4773721B2 (enExample)
CN (1) CN100589809C (enExample)
AT (1) ATE386532T1 (enExample)
AU (1) AU2003276957A1 (enExample)
BR (1) BR0311722A (enExample)
CA (1) CA2487332C (enExample)
CY (1) CY1108099T1 (enExample)
DE (1) DE60319221T2 (enExample)
DK (1) DK1515729T3 (enExample)
ES (1) ES2301807T3 (enExample)
PT (1) PT1515729E (enExample)
SI (1) SI1515729T1 (enExample)
WO (1) WO2003105867A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100678824B1 (ko) * 2005-02-04 2007-02-05 한미약품 주식회사 용해성이 증가된 무정형 타크로리무스 고체분산체 및 이를포함하는 약제학적 조성물
BRPI0709409A2 (pt) 2006-03-28 2011-07-12 Javelin Pharmaceuticals Inc composição farmacêutica e método para tratar um mamìfero necessitando de analgesia
WO2008120249A1 (en) * 2007-03-30 2008-10-09 Sifi S.P.A. Pharmaceutical formulations based on apolar and polar lipids for ophthalmic use
CN101757621B (zh) * 2008-11-28 2012-07-04 天津金耀集团有限公司 一种眼部抗炎的环糊精包合药物组合物
US9642920B2 (en) * 2009-06-03 2017-05-09 Case Western Reserve University Therapeutic agent delivery system and method
CN102276761A (zh) * 2010-06-11 2011-12-14 南京理工大学 单取代铵基正电型-β-环糊精及其制备方法
GB201114459D0 (en) * 2011-08-22 2011-10-05 Isis Innovation Anti-bacterial compounds
CN103497275B (zh) * 2013-08-09 2015-12-23 华北电力大学（保定） 一种抗菌、抗病毒胍盐星形聚合物及其制备方法和应用
CZ307458B6 (cs) * 2014-11-25 2018-09-12 Spur A.S. Vícevrstvý kryt rány s aktivní vrstvou a způsob jeho výroby
EP3227379B1 (en) * 2014-12-02 2020-07-29 B.G. Negev Technologies and Applications Ltd., at Ben-Gurion University Quaternized starches for use as anti-microbial agents
CN109487588B (zh) * 2018-11-19 2021-04-20 绍兴永通印花有限公司 一种印花用涤纶织物处理液及其使用方法
BR112021014889A2 (pt) * 2019-02-14 2021-10-05 Cyclopure, Inc. Materiais poliméricos de ciclodextrina com carga e métodos de fabricação e uso dos mesmos
CN109836512A (zh) * 2019-03-04 2019-06-04 西南石油大学 一种新型β-CD双子表面活性剂为稠化剂的清洁压裂液
CN112386710A (zh) * 2020-12-09 2021-02-23 星拜(苏州)生物科技有限公司 一种利用包埋技术改善紫檀芪水溶性的方法
CN116987213B (zh) * 2022-04-26 2025-09-09 中国石油化工股份有限公司 一种具有表面活性剂功能的化合物、一种表面活性剂及其制备方法
CN120435346A (zh) 2023-01-12 2025-08-05 赛克洛珀股份有限公司 聚合环糊精吸附剂的再生

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3453257A (en) * 1967-02-13 1969-07-01 Corn Products Co Cyclodextrin with cationic properties
JPS58210901A (ja) * 1982-06-01 1983-12-08 Kao Corp シクロデキストリン誘導体およびその製造方法
IT1229133B (it) * 1989-03-09 1991-07-22 Farmhispania Sali ammonici di policiclodestrine per l'impiego come agenti ipocolesterolemizzanti
KR927003645A (ko) * 1990-05-21 1992-12-18 후지다 히로미찌 씨클로덱스트린 유도체
JPH0481401A (ja) * 1990-07-24 1992-03-16 Toppan Printing Co Ltd シクロデキストリン誘導体
JPH0665307A (ja) * 1992-06-17 1994-03-08 Sankyo Co Ltd シクロデキストリン誘導体
US5891913A (en) * 1994-10-10 1999-04-06 Novartis Finance Corporation Ophthalmic and aural compositions containing diclofenac potassium
JP3297969B2 (ja) * 1994-12-26 2002-07-02 ライオン株式会社 点眼剤
US5869079A (en) * 1995-06-02 1999-02-09 Oculex Pharmaceuticals, Inc. Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
TW434023B (en) * 1995-09-18 2001-05-16 Novartis Ag Preserved ophthalmic composition
NZ505951A (en) * 1998-02-23 2003-02-28 Cyclops Ehf A method for enhancing the complexation efficiency of a heterocyclic drug with cyclodextrin, by subjecting the heterocycloc drug to chemically reversible ring-opening

Also Published As

Publication number Publication date
CN100589809C (zh) 2010-02-17
JP2005529175A (ja) 2005-09-29
US20050222085A1 (en) 2005-10-06
SI1515729T1 (sl) 2008-08-31
BR0311722A (pt) 2005-03-01
US20090110734A1 (en) 2009-04-30
ATE386532T1 (de) 2008-03-15
US20130137657A1 (en) 2013-05-30
CY1108099T1 (el) 2014-02-12
PT1515729E (pt) 2008-05-30
DK1515729T3 (da) 2008-06-16
WO2003105867A1 (en) 2003-12-24
JP4773721B2 (ja) 2011-09-14
EP1515729B1 (en) 2008-02-20
CA2487332C (en) 2012-05-15
US20120004158A1 (en) 2012-01-05
DE60319221D1 (de) 2008-04-03
JP2011006448A (ja) 2011-01-13
CA2487332A1 (en) 2003-12-24
DE60319221T2 (de) 2009-03-05
ES2301807T3 (es) 2008-07-01
CN1658888A (zh) 2005-08-24
EP1515729A1 (en) 2005-03-23

Similar Documents

Publication Publication Date Title
AU2003276957A1 (en) Quaternised ammonium cyclodextrin compounds
WO2004014384A3 (en) Cyclic compounds containing zinc binding groups as matrix metalloproteinase inhibitors
HRP20060276A2 (en) 6-0-supstituted ketolides having antibacterial activity
EP1481965A4 (en) AROMATIC AMINO ACID DERIVATIVES AND MEDICAL COMPOSITIONS
AP9801378A0 (en) 9-amino-3- keto erythromycin derivatives.
CA2040905A1 (en) Carbohydrate derivatives comprising a trisaccharide unit
RU2450015C2 (ru) Производные аминотиазола и их применение в качестве антибактериальных средств
BR0315302A (pt) Benzoxazinonas substituìdas e seus usos
DE602005009924D1 (en) Synthetische multiple quaternäre ammoniumsalze
AU2003210203A1 (en) Aqueous dispersions consisting of polycarbodiimides
MD1788G2 (ro) Derivaţi de 9-O-oximă ai Eritromicinei A, compoziţie farmaceutică pe baza lor şi metodă de tratament al bolilor infecţioase
HUP9902465A1 (hu) Új amidínium-származékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
WO2004062562A3 (en) Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
RU2207344C2 (ru) Производное сложного эфира n-алкиласпартилдипептида и подслащивающий агент
EP1027880A3 (de) Verwendung von quaternären Ammoniumverbindungen als Antitranspirantien
AR012883A1 (es) Compuestos derivados de ciclobutilamina sustituida, composicion farmaceutica y agente antibacteriano.
HUP0204217A2 (en) Novel a-500359 derivatives
AU6734798A (en) New derivatives of erythromycin, their preparation process and their use as medicaments
Pruess et al. ANTIMETABOLITES PRODUCED BY MICROORGANISMS. XI. 1) 1-(S)-HYDROXY-2-(S, S)-VALYLAMIDO-CYCLOBUTANE-1-ACETIC ACID
RU94022756A (ru) Агент, ускоряющий разрастание эндотелиальных клеток
EP4242249A8 (en) Surface treatment agent
TW200724145A (en) Substituted acrylamide derivatives and pharmaceutical compositions thereof
ES440147A1 (es) Un proceso para la preparacion de derivados de la nitrosou- rea.
RU2220151C2 (ru) Стероидные производные, способы их получения, фармацевтическая композиция, способ лечения, способ подавления роста микробов
CA2234164A1 (en) Novel orthosomycins from micromonospora carbonacea

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase